where was glp 1 discovered The discovery and development of GLP-1 based drugs that have revolutionized the treatment of obesity Discovery of GLP-1–Based Drugs for

(By utilization, we mean the percentage of stipend dollars actually used

The purpose of the ACHIEVE-1 trial was to help determine the efficacy and safety of orforglipron for: Reduction in HbA1c (a measure of blood glucose) from a baseline of 8.0% Weight loss A key secondary endpoint was the proportion of participants achieving target A1C levels

In patients with T2D, chronic hyperglycaemia, as evidenced by high HbA1c levels, is strongly related to the risk of cardiovascular disease (CVD) and death by inducing oxidative stress and inflammation and promoting atherosclerosis and endothelial dysfunction

Bidirectional relationship between acute pancreatitis and pancreatic cancer

Tirzepatide impressive weight loss as compared to Semaglutide, was because it was a more potent GLP-1 or because of synergistic effect of GIP